GMO Benchmark-Free Allocation Fund Class III GBMFX

Medalist Rating as of | See GMO Investment Hub
  • NAV / 1-Day Return 34.05  /  +0.18 %
  • Total Assets 2.7B
  • Adj. Expense Ratio
    1.350%
  • Expense Ratio 0.660%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Global Moderate Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity High/Limited
  • Status Open
  • TTM Yield 3.76%
  • Turnover 11%

USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0

Morningstar’s Analysis GBMFX

Will GBMFX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

A consistent, if unconstrained, execution of valuation-driven investing.

Analyst Vedran Beogradlija

Vedran Beogradlija

Analyst

Summary

GMO Benchmark-Free Allocation stands apart from peers as a pure expression of the firm’s valuation-focused investment philosophy. An expert duo backed by robust resources shepherds the strategy, but the unconstrained approach can face unique challenges.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GBMFX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 28.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Us 2yr Note (Cbt)

20.59 533M
Government

United States Treasury Notes 3.87%

10.97 284M
Government

Us 5yr Note (Cbt)

9.74 252M
Government

10 Year Treasury Note Future Sept 26

5.97 155M
Government

Ultra 10 Year US Treasury Note Future Sept 26

4.45 115M
Government

Meta Platforms Inc Class A

4.30 111M
Communication Services

United States Treasury Notes 3.96%

4.11 107M
Government

United States Treasury Notes 3.93%

3.98 103M
Government

United States Treasury Notes 1.88%

3.50 91M
Government

Contra Derivatives - Futures

−39.38 −1B
—

Sponsor Center